For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Genelabs, Incorporated

USPTO Granted Patents = 17

Forward Citations = 242

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Gregory R Reyes (5 out of 27 patents)

Kou M Hwang (5 out of 6 patents)

Michael S McGrath (4 out of 26 patents)

4. Su-Ying Liu (4 out of 6 patents)

5. You M Qi (4 out of 5 patents)

6. Theresa P Chow (3 out of 4 patents)

7. Michael Piatak (3 out of 5 patents)

8. Kirk E Fry (2 out of 39 patents)

9. Valerie L Ng (2 out of 3 patents)

10. Jen Chen (2 out of 7 patents)

11. William Choy (2 out of 3 patents)

12. Linda B Rabin (2 out of 2 patents)

13. Hin-Wing Yeung (2 out of 2 patents)

14. Jeffrey D Lifson (2 out of 2 patents)

15. Edgar George Engleman (1 out of 46 patents)

17 patents: Sort by Forward Citations

1. 5443965 - Hepatitis C virus epitopes (1995-08-22),

2. 5441983 - Treatment of infection by enveloped virus with calix(N)arene compounds (1995-08-15),

3. 5409959 - Antithrombotic treatment with calix(n)arene compounds (1995-04-25),

4. 5218099 - Post-transfusion, non-A, non-B hepatitis virus polynucleotides (1993-06-08),

5. 5196452 - Macrocyclic anti-viral compound and method (1993-03-23),

6. 5169753 - Method and kit for detecting human retrovirus (1992-12-08),

7. 5166173 - Method of treating herpes simplex virus infection (1992-11-24),

8. 5166056 - Recombinant trichosanthin and coding sequence (1992-11-24),

9. 5128460 - Recombinant trichosanthin and coding sequence (1992-07-07),

10. 5108920 - Retrovirus isolated from human lymphoma cell lines (1992-04-28),

11. 5101025 - Recombinant trichosanthin and coding sequence (1992-03-31),

12. 5077390 - Purified trichosanthin and method of preparation (1991-12-31),

13. 5066579 - HTLV-I peptide antigen and assay (1991-11-19),

14. 4869903 - Method of selectively inhibiting HIV (1989-09-26),

15. 4851210 - Blood typing device (1989-07-25),

Genelabs, Incorporated is a leading biotechnology company specializing in drug discovery and development. With a focus on innovative research and cutting-edge technology, Genelabs is committed to advancing medical science and improving patient outcomes. The company's experienced team of scientists and researchers work tirelessly to bring new therapies to market, with a goal of addressing unmet medical needs and improving quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

17 Patents

#103 in Redwood City, CA

#4,505 in California

#18,865 in US

#35,857 in the World

Redwood City, CA, United States of America

Genelabs, Incorporated

Forward Citations = 242

27 inventors:

Gregory R Reyes (5 out of 27 patents)

Kou M Hwang (5 out of 6 patents)

Michael S McGrath (4 out of 26 patents)

4. Su-Ying Liu (4 out of 6 patents)

5. You M Qi (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…